Protein kinase inhibitor: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 06:15, 11 February 2025
Protein kinase inhibitors are a type of enzyme inhibitor that block the action of one or more protein kinases. They are often used in the treatment of cancer and inflammation.
Mechanism of action
Protein kinase inhibitors work by binding to the active site of a protein kinase, preventing it from phosphorylating other proteins. This can disrupt the signaling pathways that the kinase is involved in, potentially leading to the death of cancer cells or the reduction of inflammation.
Types
There are several types of protein kinase inhibitors, including tyrosine kinase inhibitors, serine/threonine kinase inhibitors, and dual-specificity kinase inhibitors. Each type inhibits a different class of protein kinases, and they are used to treat different types of diseases.
Uses
Protein kinase inhibitors are used in the treatment of a variety of diseases, including cancer, inflammation, and certain autoimmune diseases. They are also used in research to study the function of protein kinases.
Side effects
Like all drugs, protein kinase inhibitors can have side effects. These can include nausea, vomiting, diarrhea, and fatigue. In some cases, they can also cause more serious side effects, such as heart problems or liver damage.


